Replies to post #41511 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Blue I am hoping for the best, but not sure what we have is gold. Considering we are already a late stage company if it were gold our valuation would be a lot higher, similar to the CART companies whose valuations were already in the billions when they started phase 3s. The reality is we are barely over $100 million. No doubt we should be considerably higher, just not sure we will ever be in the multi billion or we would already be over a billion now.

[trading_cyclist]

Agree on all points. We will sell for $40 or more. End of discussion.

[Batermere]

I'm not a TRADER, a SHORT, or looking to buy more shares under $3. I'm loaded to the gills already with a DCA at $10. So the choices are #1: SELL THE COMPANY in the next 2-3 months for hopefully $25-30/share and make a nice return and the NIGHTMARE is over OR, #2: HOLD ON PATIENTLY and pray to God daily for all 4 constructs to be sold individually for what will be BOOKOO BUCKS if everything goes absolutely perfect for $50/share or more. Sorry, but myself and 99% of the LONGS that post here will take option #1. A BIRD IN THE HAND IS WORTH TWO IN THE BUSH.

[Mazo1]

I Agree Blue, patients is the key, and will provide rewards over all with not just investors, but cancer patients as well

[MadCityCyclone]

Companies need to be able to fund operations. What is "full potential" for shareholders if they fund operations by dilution at this price? They are painted into a corner.